Clinical Trial Update: Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study) [Phase 4]

View source ↗

Summary

Phase 4 INITIATE trial evaluating different Factor VIII doses and dosing frequencies for immune tolerance induction with ADVATE in boys with Hemophilia A with i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Drugs mentioned

• ADVATE (antihemophilic factor VIII)

Snippet

Sponsor: Runhui WU | Conditions: Hemophilia a with Inhibitor | Phase 4 | Status: RECRUITING